SCHEMBL8622014

SCHEMBL8622014

ICCCc1ccc(OCCc2ccccc2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.61
RAB9A P51151 1/20 0.61
FFAR1 O14842 3/20 0.58
LTA4H P09960 4/20 0.57
DRD2 P14416 1/20 0.53
DRD4 P21917 1/20 0.53
DRD3 P35462 1/20 0.53
CA12 O43570 1/20 0.53
CA1 P00915 1/20 0.53
CA2 P00918 1/20 0.53
CA7 P43166 1/20 0.53
CA9 Q16790 1/20 0.53
EPHX2 P34913 1/20 0.51
S1PR1 P21453 3/20 0.49
S1PR3 Q99500 1/20 0.49
ALDH1A1 P00352 1/20 0.48
HPGD P15428 1/20 0.48
ALOX15 P16050 1/20 0.48
ALOX12 P18054 1/20 0.48
CASP1 P29466 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8420664 0.91 KCNA3 (0.59) NPC1RAB9AFFAR1LTA4HDRD2
SCHEMBL7619641 0.87 FFAR1 (0.66) NPC1RAB9AFFAR1LTA4HDRD2
SCHEMBL8498709 0.86 FFAR1 (0.64) NPC1RAB9AFFAR1LTA4HDRD2
SCHEMBL1562483 0.86 LTA4H (0.70) FFAR1LTA4HEPHX2
SCHEMBL4516286 0.86 KCNA3 (0.57) FFAR1DRD2DRD4DRD3S1PR1
SCHEMBL28533454 0.85 FFAR1 (0.67) NPC1RAB9AFFAR1LTA4HCA12
SCHEMBL9456979 0.84 NPC1 (0.80) NPC1RAB9AFFAR1LTA4HDRD2
SCHEMBL8422546 0.83 KCNA3 (0.64) NPC1RAB9AFFAR1LTA4HDRD2
SCHEMBL5542045 0.82 NPC1 (0.61) NPC1RAB9AFFAR1LTA4HDRD2
SCHEMBL5542414 0.81 NPC1 (0.59) NPC1RAB9AFFAR1LTA4HDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5712396-A PHOSPHONOSULFONATE COMPOUNDS USED FOR INHIBITING CHOLESTEROL BIOSYNTHESIS AND ATHEROSCLEROSIS MAGNIN DAVID R (US) 1998-01-27 US disclosed
US-5567841-A ANTICHOLESTEROL AGENT BRISTOL-MYERS SQUIBB COMPANY (US) 1996-10-22 US disclosed
US-5470845-A Methods of using α-phosphonosulfonate squalene synthetase inhibitors including the treatment of atherosclerosis and hypercholesterolemia BRISTOL-MYERS SQUIBB COMPANY (US) 1995-11-28 US disclosed